CC-885 is primarily explored for its potential in cancer therapy, particularly in targeting and eliminating cancer cells through specific molecular pathways. It functions by inducing cell death in certain types of cancer, making it a promising candidate for developing novel treatments. Researchers are investigating its efficacy in preclinical studies, focusing on its ability to selectively kill cancer cells while sparing healthy ones. This compound is also being studied for its role in overcoming drug resistance, a significant challenge in cancer treatment. Its application could lead to more effective and targeted therapies for various malignancies.